Nanology Labs Secures $3 Million in Oversubscribed Seed Round

Nanology Labs, an IND-stage company developing next generation nanomedicines to conquer cancer, announced, on May 17, that its seed capital raise was oversubscribed at $3M. The round was led by FACIT with co-investors Creative Destruction Lab Angels, Ontario Brain Institute, Ontario Center of Innovation, and MEDTEQ.